v3 Template
I

Iterum Therapeutics plc

Pharmaceuticals Dublin and Chicago ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$27.7M
Funding Rounds
4
Last Funding
2025-04-30

About Iterum Therapeutics plc

Iterum Therapeutics plc is a clinical-stage pharmaceutical company dedicated to developing significantly differentiated anti-infectives to combat the global crisis of multi-drug resistant (MDR) pathogens.

Products & Services

Sulopenem:The first oral and IV penem antibiotic with potent activity against multi-drug resistant gram-negative infections in hospital and community settings.
ORLYNVAH™:A medicine listed under the company's portfolio, though specific details are not provided in the content.

Specialties

Anti-infectives Multi-drug resistant (MDR) pathogens Antibiotic development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 5000000
MR: -
FA: 5 million
FAN: 5000000
D: 2025-04-30
FD: 2025-04-30
1 investors
2 RT: Registered Direct Offering
T: -
FT: Registered Direct Offering
A: 5000000
MR: -
FA: $5 million
FAN: 5000000
D: 2025-04-29
FD: 2025-04-29
1 investors
3 RT: Rights Offering
T: -
FT: Rights Offering
A: 7400000
MR: -
FA: approximately $7.4 million
FAN: 7400000
D: 2024-08-06
FD: 2024-08-06
-
4 RT: Rights Offering
T: -
FT: Rights Offering
A: 10289599
MR: -
FA: 8,503,800 units at $1.21 per unit
FAN: 10289599
D: 2024-07-22
FD: 2024-07-22
-
Registered Direct Offering Latest
2025-04-30
$5.0M
1 investor (Pro only)
Registered Direct Offering 2025-04-29
$5.0M
Rights Offering 2024-08-06
$7.4M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michael Dunne

Director

C

Corey N. Fishman

Chief Executive Officer

B

Beth P. Hecht

Director

D

David G. Kelly

Director and Chairman of the Board

J

Joe Whalen

Director

J

Judith M. Matthews

Chief Financial Officer

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Iterum Therapeutics plc Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Pharmaceuticals
Company Size
~150 employees (est.)
Locations
Dublin and Chicago

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro